Cost Plus Drugs co-founder berates benefit advisers for not emphasizing cash carveouts as he seeks to better educate CEOs on how to avoid being ripped off.

With premiums climbing, benefit leaders rely on claims data and analytic tools to guide smarter plan design and purchasing.

With about 7 million additional Americans expected to sign up for HSAs, these vehicles can help finance costly GLP-1s.

The industry asked for and received a delay in the rule from the IRS in 2023. Now that it's going into effect, here are the key implications for sponsors and savers.

As pets become more prominent in employees' lives, some employers are actually extending bereavement leave for the loss of fur babies.

As many as 70% of Americans don't have a will, trust, health or funeral directive as the nation gears up for its largest wealth transfer ever.

Advisers can help employers compete for C-suite talent amid major demographic shifts by highlighting nonqualified plans to supplement core benefits.

The Social Security Administration announced its cost-of-living adjustment for beneficiaries — a figure advocates say fails to address the reality for most seniors.

Pressure continues to mount on producers to deliver more customized benefit packages and consultative services to satisfy the needs of more demanding clients.

Key to cost containment lies in partnering with transparent PBMs, a more thoughtful approach to prescribing GLP-1s and encouraging the uptake of biosimilars.

Brown & Brown's Erika Illiano suggests finding the right decision-support tool and constructing a compelling narrative around various coverage options.